Genetic alterations of NOP2 were most frequent in ovarian cancer (6.1%) and patients with NOP2 genetic alterations were associated with poorer OS, DSS, and PFS in the cBioPortal cohort analysis. This evidence concerns the gene NOP2 and ovarian cancer.